EBO
vs
NZX All Share
Over the past 12 months, EBO has underperformed NZX All Share, delivering a return of 3% compared to the NZX All Share's 5% growth.
Stocks Performance
EBO vs NZX All Share
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
US |
Mckesson Corp
NYSE:MCK
|
||
US |
Cencora Inc
NYSE:COR
|
||
US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
|
US |
Cardinal Health Inc
NYSE:CAH
|
||
US |
Henry Schein Inc
NASDAQ:HSIC
|
||
KR |
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
||
CN |
Sinopharm Group Co Ltd
HKEX:1099
|
||
CN |
Huadong Medicine Co Ltd
SZSE:000963
|
||
CN |
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
||
IT |
Amplifon SpA
MIL:AMP
|
Performance Gap
EBO vs NZX All Share
US |
Mckesson Corp
NYSE:MCK
|
||
US |
Cencora Inc
NYSE:COR
|
||
US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
|
US |
Cardinal Health Inc
NYSE:CAH
|
||
US |
Henry Schein Inc
NASDAQ:HSIC
|
||
KR |
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
||
CN |
Sinopharm Group Co Ltd
HKEX:1099
|
||
CN |
Huadong Medicine Co Ltd
SZSE:000963
|
||
CN |
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
||
IT |
Amplifon SpA
MIL:AMP
|
Performance By Year
EBO vs NZX All Share
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
US |
Mckesson Corp
NYSE:MCK
|
||
US |
Cencora Inc
NYSE:COR
|
||
US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
|
US |
Cardinal Health Inc
NYSE:CAH
|
||
US |
Henry Schein Inc
NASDAQ:HSIC
|
||
KR |
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
||
CN |
Sinopharm Group Co Ltd
HKEX:1099
|
||
CN |
Huadong Medicine Co Ltd
SZSE:000963
|
||
CN |
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
||
IT |
Amplifon SpA
MIL:AMP
|
Competitors Performance
EBOS Group Ltd vs Peers
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
US |
G
|
GE Vernova LLC
NYSE:GEV
|
|
NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
|
US |
Schlumberger NV
NYSE:SLB
|
||
US |
B
|
Baker Hughes Co
NASDAQ:BKR
|
|
ID |
Amman Mineral Internasional Tbk PT
IDX:AMMN
|
||
US |
R
|
Reddit Inc
NYSE:RDDT
|
|
CH |
G
|
Galderma Group AG
SIX:GALD
|
|
US |
Halliburton Co
NYSE:HAL
|
||
LU |
Tenaris SA
MIL:TEN
|
||
IN |
Jio Financial Services Ltd
NSE:JIOFIN
|
EBOS Group Ltd
Glance View
In the sprawling landscape of the Australasian healthcare and animal care markets, EBOS Group Ltd. stands as a towering presence, orchestrating a symphony of operations that span distribution, logistics, and retail. Established decades ago, EBOS has meticulously expanded its footprint to become a vital linchpin in the supply chain of healthcare and animal care products. Understanding its core operations is akin to peering into a well-oiled machine where efficiency reigns supreme. At the heart of EBOS's business model is its distribution segment, which acts as a conduit for pharmaceutical and healthcare products from manufacturers to a diverse range of clients including hospitals, pharmacies, and aged care facilities. This seamless distribution network is supported by state-of-the-art logistics capabilities, enabling the company to ensure timely and reliable delivery of crucial healthcare supplies across the region. Beyond distribution, EBOS has judiciously diversified into animal care and retail, recognizing the intertwining of human and animal welfare in contemporary lifestyles. Its procurement and distribution of veterinary products capitalize on the robust and growing pet care market, which has seen a surge in demand as households increasingly consider pets as part of the family. The company's retail arm, featuring well-known banners like TerryWhite Chemmart, brings it closer to consumers, providing a direct link to end-users and fortifying its revenue streams. By embracing these complementary business segments, EBOS not only ensures a balanced portfolio but also leverages synergies to maximize profit margins. Thus, through a blend of comprehensive distribution networks and strategic retail positions, EBOS Group Ltd. adeptly maneuvers within its markets, translating efficiency and scale into consistent, sustainable growth.